ContractProvision of Services for Clinical Study • February 19th, 2019
Contract Type FiledFebruary 19th, 2019AGREEMENT ON PROVISION OF SERVICES AND PREMISES FOR EXECUTION OF CLINICAL STUDY This Agreement on Provision of Services and Premises for Execution of Clinical Study (“Agreement”) is effective as of the date of publishing in the Register of Contracts (“Effective Date”) between Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, Massachusetts 02210 USA, Company registration number [Tax ID: 043039129] as represented by Mary-Lynn Fulton, Senior Director, Study Management, appointing as its legal representative in the EU with regard to liability (art. 19 EU Directive 2001/83) Vertex Pharmaceuticals (Europe) Limited, with the registered office at 2 Kingdom Street, London, W2 6BD, United Kingdom (“Vertex”), and Fakultní nemocnice v Motole, Government contributory organisation, V Úvalu 84, 150 06 Praha 5, Czech Republic, Company registration number: 00064203, VAT No.: CZ00064203 asrepresented by director JUDr. Ing. Miloslavem Ludvíkem, MBA (“Healthcare Service Provider” or “Provid